Inactive Instrument

Weifa ASA Stock price

Equities

WEIFA

NO0010308240

Pharmaceuticals

Dynamic Chart
Weifa ASA Announces Board Appointments CI
Karo Pharma AB (OM:KARO) completed the acquisition of Weifa ASA (OB:WEIFA) from Holta Life Sciences AS, Watrium AS and others. CI
An unknown buyer acquired 9.1% stake in Weifa ASA (OB:WEIFA) from MVN Event Driven Master Fund Limited fund managed by MVN Asset Management Limited and MVN Asset Management Limited. CI
Weifa ASA(OB:WEIFA) dropped from S&P Global BMI Index CI
Karo Pharma AB (OM:KARO) entered into a transaction agreement to make an offer to acquire Weifa ASA (OB:WEIFA) from Holta Life Sciences AS, Watrium AS and others for NOK 1.3 billion. CI
Weifa ASA Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017; Provides Earnings Guidance for the Year 2017 CI
Weifa ASA Announces Dividend, Payable on June 8, 2017 CI
Weifa ASA Announces Audited Consolidated and Parent Earnings Results for the Year Ended December 31, 2016 CI
The mutual funds managed by Nordea Funds Oy acquired an additional 0.54% stake in Weifa ASA (OB: WEIFA). CI
Weifa ASA Proposes Dividend for the Fourth Quarter of 2016, Payable on June 8, 2017 CI
Weifa ASA Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2016 CI
Weifa Announces New License Agreement with AFT Pharmaceuticals for Nordic Rights to Groundbreaking Product Line Within Pain Management CI
Weifa ASA Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2016; Provides Earnings Guidance for 2016 CI
Weifa ASA to Launch Lbux(R) 200 mg Soft Capsules to Strengthen its Pain Relief Portfolio CI
Weifa ASA Launches Solvivo(R) Lozenges CI
More news
  1. Stock
  2. Equities
  3. Stock Weifa ASA - Oslo Bors